在神经退行性疾病中重复性跨体磁性刺激:系统性审查和剂量-反应元分析
Yu Zhang1, Yulin Wang1, Ke Xu1
1The Second Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin Heilongjiang Province, China.
Frontiers in aging neuroscience
|July 25, 2025
概括
重复的跨磁刺激 (rTMS) 有效地治疗帕金森氏症.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 医疗技术 医疗技术 医学技术
背景情况:
- 帕金森病 (PD) 和阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,具有显著的未满足的临床需求.
- 重复性横磁刺激 (rTMS) 是一种非侵入性神经调节技术,用于治疗各种神经疾病.
- 对于PD和AD的rTMS现有的临床证据需要合成和定量分析来确定最佳的治疗参数.
研究的目的:
- 系统地审查和对治疗帕金森病和阿尔茨海默病中的rTMS临床证据进行元分析.
- 为了确定rTMS脉冲数和运动和非运动症状的治疗疗效之间的剂量反应关系.
- 确定最佳的rTMS参数,以最大限度地提高PD和AD患者的治疗效益.
主要方法:
- 在五个数据库中进行了全面的文献搜索,以确定相关的临床研究.
- 来自51个出版物,涉及1938名受试者的数据被提取用于元分析.
- 限制立方脊线 (RCS) 分析用于建模剂量反应曲线,评估rTMS脉冲计数和效果大小 (SMD) 之间的关系.
主要成果:
- rTMS在PD和AD患者的特定运动和非运动症状方面表现出显著的疗效.
- 剂量反应分析显示了PD中几个结果的显著钟形曲线,包括TUG,FOGQ,BDI,HAMD和HAMA.
- 同样,在AD患者的MMSE和MoCA得分中观察到显著的钟形曲线,表明与rTMS脉数的非线性关系.
结论:
- rTMS是一种有效的治疗干预,用于选择与帕金森病和阿尔茨海默病相关的运动和非运动症状.
- rTMS的治疗疗效遵循钟形的剂量反应曲线,表明存在最佳数量的脉冲.
- 超过rTMS脉冲的最佳数量可能会导致治疗效果减弱甚至负面,这凸显了精确参数选择的重要性.
相关概念视频
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...


